Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	8 Months Ended
	Sep. 06, 2015		Sep. 07, 2014
Cash flows from operating activities:
Net income	$ 130,030		$ 114,554
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	22,695		20,024
Gains on sale/disposal of assets	(73)		(1,381)
Amortization of deferred financing costs	3,825		4,046
Provision for deferred income taxes	959		1,008
Non-cash compensation expense	11,188		11,897
Tax impact from equity-based compensation	(15,745)		(10,899)
Other	(1,216)		(888)
Changes in operating assets and liabilities	15,645		(19,476)
Net cash provided by operating activities	167,308		118,885
Cash flows from investing activities:
Capital expenditures	(33,834)		(30,983)
Proceeds from sale of assets	10,464		5,802
Changes in restricted cash	29,933		51,861
Other	1,304		(1,365)
Net cash provided by investing activities	7,867		25,315
Cash flows from financing activities:
Proceeds from issuance of long-term debt	5,000
Repayments of long-term debt and capital lease obligations	(5,198)		(12,152)
Proceeds from exercise of stock options	4,459		3,094
Tax impact from equity-based compensation	15,745		10,899
Purchases of common stock	(138,550)		(82,407)
Tax payments for restricted stock upon vesting	(7,442)		(7,889)
Payments of common stock dividends and equivalents	(48,141)		(39,208)
Net cash used in financing activities	(174,127)		(127,663)
Effect of exchange rate changes on cash and cash equivalents	603		16
Change in cash and cash equivalents	1,651		16,553
Cash and cash equivalents, at beginning of period	30,855	[1]	14,383
Cash and cash equivalents, at end of period	$ 32,506		$ 30,936

[1] The balance sheet at December 28, 2014 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.